Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy.
Sabatino M, Kim-Schulze S, Panelli MC, Stroncek D, Wang E, Taback B, Kim DW, Deraffele G, Pos Z, Marincola FM, Kaufman HL.
Sabatino M, et al. Among authors: kim dw, kim schulze s.
J Clin Oncol. 2009 Jun 1;27(16):2645-52. doi: 10.1200/JCO.2008.19.1106. Epub 2009 Apr 13.
J Clin Oncol. 2009.
PMID: 19364969
Free PMC article.
Clinical Trial.